Condensed Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2018	Mar. 31, 2017
Revenues:
Premiums and policy fees		$ 2,649,971	$ 2,702,754
Ceded reinsurance premiums and policy fees		(738,965)	(726,654)
Net investment income		3,068,118	3,036,484
Other income		60,935	115,959
Revenues before realized gains (losses)		5,040,059	5,128,543
Net investment gains (losses):
Other-than-temporary impairments		0	(484,347)
Other realized investment gains, net		534,242	(14,344)
Change in fair value of equity securities		4,129,236	0
Net investment gains (losses)	[1]	4,663,478	(498,691)
Total revenue		9,703,537	4,629,852
Benefits, claims and settlement expenses:
Life		4,168,794	4,967,652
Ceded reinsurance benefits and claims		(688,412)	(286,110)
Annuity		256,884	243,397
Dividends to policyholders		126,999	113,286
Commissions and amortization of deferred policy acquisition costs		(40,571)	(35,981)
Amortization of cost of insurance acquired		201,516	209,776
Operating expenses		2,085,819	2,046,057
Total benefits and other expenses		6,111,029	7,258,077
Income (loss) before income taxes		3,592,508	(2,628,225)
Income tax (expense) benefit		905,763	(513,590)
Net income		2,686,745	(2,114,635)
Net income attributable to noncontrolling interests		(29,500)	141,234
Net income attributable to common shareholders		$ 2,657,245	$ (1,973,401)
Amounts attributable to common shareholders:
Basic income (loss) per share (in dollars per share)		$ 0.80	$ (0.59)
Diluted income (loss) per share (in dollars per share)		$ 0.80	$ (0.59)
Basic weighted average shares outstanding (in shares)		3,325,111	3,350,248
Diluted weighted average shares outstanding (in shares)		3,325,111	3,350,248

[1] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale with unrealized gains and losses recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net income. Prior periods have not been restated to conform to the current presentation. See note 2.